Cargando…

Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study

Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same...

Descripción completa

Detalles Bibliográficos
Autores principales: Lobenwein, Daniela, Huber, Rosalie, Kerbler, Lars, Gratl, Alexandra, Wipper, Sabine, Gollmann-Tepeköylü, Can, Holfeld, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027844/
https://www.ncbi.nlm.nih.gov/pubmed/35456206
http://dx.doi.org/10.3390/jcm11082115
_version_ 1784691468530614272
author Lobenwein, Daniela
Huber, Rosalie
Kerbler, Lars
Gratl, Alexandra
Wipper, Sabine
Gollmann-Tepeköylü, Can
Holfeld, Johannes
author_facet Lobenwein, Daniela
Huber, Rosalie
Kerbler, Lars
Gratl, Alexandra
Wipper, Sabine
Gollmann-Tepeköylü, Can
Holfeld, Johannes
author_sort Lobenwein, Daniela
collection PubMed
description Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury.
format Online
Article
Text
id pubmed-9027844
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90278442022-04-23 Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study Lobenwein, Daniela Huber, Rosalie Kerbler, Lars Gratl, Alexandra Wipper, Sabine Gollmann-Tepeköylü, Can Holfeld, Johannes J Clin Med Article Spinal cord ischemia (SCI) is a devastating and unpredictable complication of thoracoabdominal aortic repair. Postischemic Toll-like receptor 3 (TLR3) activation through either direct agonists or shock wave therapy (SWT) has been previously shown to ameliorate damage in SCI models. Whether the same applies for pre- or postconditioning remains unclear. In a model of cultured SHSY-5Y cells, preconditioning with either poly(I:C), a TLR3 agonist, or SWT was performed before induction of hypoxia, whereas postconditioning treatment was performed after termination of hypoxia. We measured cytokine expression via RT-PCR and utilized Western blot analysis for the analysis of signaling and apoptosis. TLR3 activation via poly(I:C) significantly reduced apoptotic markers in both pre- and postconditioning, the former yielding more favorable results through an additional suppression of TLR4 and its downstream signaling. On the contrary, SWT showed slightly more favorable effects in the setting of postconditioning with significantly reduced markers of apoptosis. Pre- and post-ischemic direct TLR3 activation as well as post-ischemic SWT can decrease apoptosis and proinflammatory cytokine expression significantly in vitro and might therefore pose possible new treatment strategies for ischemic spinal cord injury. MDPI 2022-04-11 /pmc/articles/PMC9027844/ /pubmed/35456206 http://dx.doi.org/10.3390/jcm11082115 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lobenwein, Daniela
Huber, Rosalie
Kerbler, Lars
Gratl, Alexandra
Wipper, Sabine
Gollmann-Tepeköylü, Can
Holfeld, Johannes
Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_full Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_fullStr Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_full_unstemmed Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_short Neuronal Pre- and Postconditioning via Toll-like Receptor 3 Agonist or Extracorporeal Shock Wave Therapy as New Treatment Strategies for Spinal Cord Ischemia: An In Vitro Study
title_sort neuronal pre- and postconditioning via toll-like receptor 3 agonist or extracorporeal shock wave therapy as new treatment strategies for spinal cord ischemia: an in vitro study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027844/
https://www.ncbi.nlm.nih.gov/pubmed/35456206
http://dx.doi.org/10.3390/jcm11082115
work_keys_str_mv AT lobenweindaniela neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT huberrosalie neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT kerblerlars neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT gratlalexandra neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT wippersabine neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT gollmanntepekoylucan neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy
AT holfeldjohannes neuronalpreandpostconditioningviatolllikereceptor3agonistorextracorporealshockwavetherapyasnewtreatmentstrategiesforspinalcordischemiaaninvitrostudy